The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $34.14

Today's change-0.15 -0.44%
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $34.14

Today's change-0.15 -0.44%
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.

AstraZeneca PLC down (U.S.)$0.15

AstraZeneca PLC closed lower Friday, dropping (U.S.)$0.15 or 0.44% to (U.S.)$34.14. Over the last five days, shares have gained 9.67%, but are currently unchanged over the last year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $34.01
  • Previous close(U.S.) $34.29
  • High(U.S.) $34.34
  • Low(U.S.) $33.47
  • Bid / Ask-- / --
  • YTD % change+0.56%
  • Volume11,506,526
  • Average volume (10-day)9,618,655
  • Average volume (1-month)7,487,794
  • Average volume (3-month)5,071,348
  • 52-week range(U.S.) $26.97 to (U.S.) $34.88
  • Beta0.73
  • Trailing P/E29.57×
  • P/E 1 year forward14.49×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield4.10%
  • Trailing EPS(U.S.) $1.15
Updated July 29 4:02 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue6,1156,3995,9456,307
Total other revenue--------
Total revenue6,1156,3995,9456,307
Gross profit5,1205,1644,9275,298
Total cost of revenue9951,2351,0181,009
Total operating expense5,0775,3114,7755,384
Selling / general / administrative2,2032,5602,2992,300
Research & development1,4291,5671,4001,356
Depreciation / amortization263360234376
Interest expense (income), net operating--------
Unusual expense (income)263102322343
Other operating expenses, total-76-513-4980
Operating income1,0381,0881,170923
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax723802931658
Income after tax625808770696
Income tax, total98-6161-38
Net income646808770697
Total adjustments to net income--------
Net income before extra. items646808770697
Minority interest21001
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items646808770697
Inc. avail. to common incl. extra. items646808770697
Diluted net income646808770697
Dilution adjustment000--
Diluted weighted average shares1,2651,2651,2651,265
Diluted EPS excluding extraordinary itemsvalue per share0.510.640.610.55
Dividends per sharevalue per share0.001.900.000.90
Diluted normalized EPSvalue per share0.741.510.860.83